Characterization of human and bovine phosphatidylethanolamine-binding protein (PEBP/RKIP) interactions with morphine and morphine-glucuronides determined by noncovalent mass spectrometry

Medical Science Monitor

Volumn 15, Issue 7, 2009, Pages

  Atmanene, Cédric ^a   Laux, Alexis ^b   Glattard, Elise ^b   Muller, Arnaud ^b   Schoentgen, Françoise ^c   Metz Boutigue, Marie Hélène ^b   Aunis, Dominique ^b   Van Dorsselaer, Alain ^a   Stefano, George B ^d   Sanglier Cianférani, Sarah ^a   Goumon, Yannick ^b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Morphine; Morphine 3 glucuronide; Morphine 6 glucuronide; Noncovalent mass spectrometry; Phosphatidylethanolamine binding protein; Protein ligand interactions; Raf 1 kinase inhibitor protein

Indexed keywords

MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE; OPIATE RECEPTOR; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHROMAFFIN CELL; COMPLEX FORMATION; CONTROLLED STUDY; COVALENT BOND; COW; DRUG PROTEIN BINDING; ELECTROSPRAY MASS SPECTROMETRY; HALF LIFE TIME; HUMAN; LIGAND BINDING; MASS SPECTROMETRY; NON COVALENT MASS SPECTROMETRY; NONHUMAN; PROTEIN PROTEIN INTERACTION; SECRETORY GRANULE; VALIDATION PROCESS; WESTERN BLOTTING;

ANIMALS; CATTLE; HUMANS; MASS SPECTROMETRY; MORPHINE DERIVATIVES; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PHOSPHATIDYLETHANOLAMINES; TITRIMETRY;

EID: 67650683939     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Stefano GB, Goumon Y, Casares F et al: Endogenous morphine. Trends Neurosci, 2000; 23: 436-442
2. Stefano GB, Cadet P, Kream RM, Zhu W: The presence of endogenous morphine signaling in animals. Neurochem Res, 2008; 33: 1933-1939
3. Kream RM, Stefano GB: De novo biosynthesis of morphine in animal cells: An evidence-based model. Med Sci Monit, 2006; 12(10): RA207-19
4. Kream RM, Stefano GB: Morphine synthesis in animals. Med Sci Monit, 2006; 12(10): ED1-2
5. Zhu W, Mantione KJ, Shen L et al: Tyrosine and tyramine increase endogenous ganglionic morphine and dopamine levels in vitro and in vivo: cyp2d6 and tyrosine hydroxylase modulation demonstrates a dopamine coupling. Med Sci Monit, 2005; 11: BR397-404
6. Zhu W, Ma Y, Bell A et al: Presence of morphine in rat amygdala: evidence for the mu3 opiate receptor subtype via nitric oxide release in limbic structures. Med Sci Monit, 2004; 10(12): BR433-39 (Pubitemid 40268549)
7. Muller A, Glattard E, Taleb O et al: Endogenous Morphine in SH-SY5Y Cells and the Mouse Cerebellum. PLoS One, 2008; 3: Epub www.plosone. org/doi/pone.0001641 (Pubitemid 351865465)
8. Guarna M, Ghelardini C, Galeotti N et al: Neurotransmitter role of endogenous morphine in CNS. Med Sci Monit, 2005; 11(6): RA190-93 (Pubitemid 40904728)
9. Kream RM, Sheehan M, Cadet P et al: Persistence of evolutionary memory: primordial six-transmembrane helical domain mu opiate receptors selectively linked to endogenous morphine signaling. Med Sci Monit, 2007; 13(12): SC5-6 (Pubitemid 350272871)
10. Glattard E, Muller A, Aunis D et al: Rethinking the opiate system? Morphine and morphine-6-glucuronide as new endocrine and neuroendocrine mediators. Med Sci Monit, 2006; 12(6): SR25-27 (Pubitemid 43854436)
11. Goumon Y, Muller A, Glattard E et al: Identification of Morphine-6-glucuronide in Chromaffin Cell Secretory Granules. J Biol Chem, 2006; 281: 8082-8089 (Pubitemid 43847426)
12. Goumon Y, Strub JM, Stefano GB et al: Characterization of a morphinelike molecule in secretory granules of chromaffin cells. Med Sci Monit, 2005; 11: MS31-34 (Pubitemid 40790947)
13. Goumon Y, Angelone T, Schoentgen F et al: The hippocampal cholinergic neurostimulating peptide, the N-terminal fragment of the secreted phosphatidylethanolamine-binding protein, possesses a new biological activity on cardiac physiology. J Biol Chem, 2004; 279: 13054-13064 (Pubitemid 38445883)
14. Grandy DK, Hanneman E, Bunzow J et al: Purification, cloning, and tissue distribution of a 23-kDa rat protein isolated by morphine affinity chromatography. Mol Endocrinol, 1990; 4: 1370-1376 (Pubitemid 20371437)
15. Lotsch J, Geisslinger G: Morphine-6-glucuronide: an analgesic of the future? Clin Pharmacokinet, 2001; 40: 485-499
16. Kilpatrick GJ, Smith TW: Morphine-6-glucuronide: actions and mechanisms. Med Res Rev, 2005; 25: 521-544
17. Schoentgen F, Seddiqi N, Bucquoy S et al: Main structural and functional features of the basic cytosolic bovine 21 kDa protein delineated through hydrophobic cluster analysis and molecular modelling. Protein Eng, 1992; 5: 295-303
18. Yeung K, Seitz T, Li S et al: Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature, 1999; 401: 173-177 (Pubitemid 29436321)
19. Roussel G, Nussbaum F, Schoentgen F et al: Immunological investigation of a 21-kilodalton cytosolic basic protein in rat brain. Dev Neurosci, 1988; 10: 65-74 (Pubitemid 18146807)
20. Saunders PT, McKinnell C, Millar MR et al: Phosphatidylethanolamine binding protein is an abundant secretory product of haploid testicular germ cells in the rat. Mol Cell Endocrinol, 1995; 107: 221-230
21. Klysik J, Theroux SJ, Sedivy JM et al: Signaling crossroads: the function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction. Cell Signal, 2008; 20: 1-9 (Pubitemid 350138364)
22. Yeung KC, Rose DW, Dhillon AS et al: Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NFkappaB activation. Mol Cell Biol, 2001; 21: 7207-7217 (Pubitemid 32953475)
23. Keller ET, Fu Z, Brennan M: The role of Raf kinase inhibitor protein (RKIP) in health and disease. Biochem Pharmacol, 2004; 68: 1049-1053 (Pubitemid 39094269)
24. Keller ET, Fu Z, Brennan M: The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein. J Cell Biochem, 2005; 94: 273-278 (Pubitemid 41420306)
25. George AJ, Holsinger RM, McLean CA et al: Decreased phosphatidylethanolamine binding protein expression correlates with Abeta accumulation in the Tg2576 mouse model of Alzheimer's disease. Neurobiol Aging, 2006; 27: 614-623 (Pubitemid 43290530)
26. Banfield MJ, Barker JJ, Perry AC, Brady RL: Function from structure? The crystal structure of human phosphatidylethanolamine-binding protein suggests a role in membrane signal transduction. Structure, 1998; 6: 1245-1254 (Pubitemid 28485957)
27. Serre L, Vallee B, Bureaud N et al: Crystal structure of the phosphatidylethanolamine- binding protein from bovine brain: a novel structural class of phospholipid-binding proteins. Structure, 1998; 6: 1255-1265 (Pubitemid 28485958)
28. Bucquoy S, Jolles P, Schoentgen F: Relationships between molecular interactions (nucleotides, lipids and proteins) and structural features of the bovine brain 21-kDa protein. Eur J Biochem, 1994; 225: 1203-1210 (Pubitemid 24342567)
29. Fenn JB, Mann M, Meng CK et al: Electrospray ionization for mass spectrometry of large biomolecules. Science, 1989; 246: 64-71 (Pubitemid 19252085)
30. Ganem B, Li YT, Henion JD: Detection of noncovalent receptor-ligand complexes by mass spectrometry. J Am Chem Soc, 1991; 113: 6294-6296
31. Katta V, Chait BT: Observation of the heme-globin complex in native myoglobin by electrospray-ionization mass spectrometry. J Am Chem Soc, 1991; 113: 8534-8535
32. Loo JA: Studying noncovalent protein complexes by electrospray ionization mass spectrometry. Mass Spectrom Rev, 1997; 16: 1-23 (Pubitemid 127583217)
33. Loo JA: Electrospray ionization mass spectrometry: a technology for studying noncovalent macromolecular complexes. Int J Mass Spectrom, 2000; 200: 175-186 (Pubitemid 32015921)
34. Hofstadler SA, Sannes-Lowery KA: Applications of ESI-MS in drug discovery: interrogation of noncovalent complexes. Nat Rev Drug Discov, 2006; 5: 585-595 (Pubitemid 43971193)
35. Heck AJ, Van Den Heuvel RH: Investigation of intact protein complexes by mass spectrometry. Mass Spectrom Rev, 2004; 23: 368-389
36. Sanglier S, Atmanene C, Chevreux G, Dorsselaer AV: Nondenaturing mass spectrometry to study noncovalent protein/protein and protein/ ligand complexes: technical aspects and application to the determination of binding stoichiometries. Methods Mol Biol, 2008; 484: 217-243
37. Courjean O, Chevreux G, Perret E et al: Modulation of E-Cadherin Monomer Folding by Cooperative Binding of Calcium Ions. Biochemistry, 2008; 47: 2339-2349 (Pubitemid 351304539)
38. Sanglier S, Bourguet W, Germain P et al: Monitoring ligand-mediated nuclear receptor-coregulator interactions by noncovalent mass spectrometry. Eur J Biochem, 2004; 271: 4958-4967 (Pubitemid 40065598)
39. Bovet C, Wortmann A, Eiler S et al: Estrogen receptor-ligand complexes measured by chip-based nanoelectrospray mass spectrometry: an approach for the screening of endocrine disruptors. Protein Sci, 2007; 16: 938-946 (Pubitemid 46683198)
40. Darmanin C, Chevreux G, Potier N et al: Probing the ultra-high resolution structure of aldose reductase with molecular modelling and noncovalent mass spectrometry. Bioorg Med Chem, 2004; 12: 3797-3806 (Pubitemid 38798241)
41. Bernier I, Jolles P: Purification and characterization of a basic 23 kDa cytosolic protein from bovine brain. Biochim Biophys Acta, 1984; 790: 174-181 (Pubitemid 15206863)
42. Vallee BS, Tauc P, Brochon JC et al: Behaviour of bovine phosphatidylethanolamine- binding protein with model membranes. Eur J Biochem, 2001; 268: 5831-5841
43. Metz-Boutigue MH, Garcia-Sablone P, Hogue-Angeletti R, Aunis D: Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites. Eur J Biochem, 1993; 217: 247-257 (Pubitemid 23305293)
44. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 1970; 227: 680-685
45. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979. Biotechnology, 1992; 24: 145-149 (Pubitemid 9256559)
46. Peschke M, Verkerk UH, Kebarle P: Features of the ESI mechanism that affect the observation of multiply charged noncovalent protein complexes and the determination of the association constant by the titration method. J Am Soc Mass Spectrom, 2004; 15: 1424-1434 (Pubitemid 39311693)
47. Bernier I, Tresca JP, Jolles P: Ligand-binding studies with a 23 kDa protein purified from bovine brain cytosol. Biochim Biophys Acta, 1986; 871: 19-23 (Pubitemid 16064521)
48. Aunis D: Exocytosis in chromaffin cells of the adrenal medulla. Int Rev Cytol, 1998; 181: 213-220
49. Smith RD, Light-Wahl KJ: The observation of non-covalent interactions in solution by electrospray ionization mass spectrometry: Promise, pitfalls and prognosis. Biological Mass Spectrometry, 1993; 22: 493-501 (Pubitemid 23263432)
50. Benkestock K, Van Pelt CK, Akerud T et al: Automated nano-electrospray mass spectrometry for protein-ligand screening by noncovalent interaction applied to human H-FABP and A-FABP. J Biomol Screen, 2003; 8: 247-256 (Pubitemid 40503603)
51. Tocchini-Valentini GD, Rochel N, Escriva H et al: Structural and Functional Insights into the Ligand-binding Domain of a Nonduplicated Retinoid X Nuclear Receptor from the Invertebrate Chordate Amphioxus. J Biol Chem, 2009; 284: 1938-1948
52. Robinson CV, Chung EW, Kragelund BB et al: Probing the Nature of Noncovalent Interactions by Mass Spectrometry. A Study of Protein-CoA Ligand Binding and Assembly. J Am Chem Soc, 1996; 118: 8646-8653 (Pubitemid 26318266)
53. Rogniaux H, Van Dorsselaer A, Barth P et al: Binding of aldose reductase inhibitors: correlation of crystallographic and mass spectrometric studies - A System for X-ray Crystallography and NMR. J Am Soc Mass Spectrom, 1999; 10: 635-647
54. Lotsch J: Opioid metabolites. J Pain Symptom Manage, 2005; 29: S10-24
55. Lotsch J: Pharmacokinetic-pharmacodynamic modeling of opioids. J Pain Symptom Manage, 2005; 29: S90-103
56. van Dorp EL, Romberg R, Sarton E et al: Morphine-6-Glucuronide: Morphine's Successor for Postoperative Pain Relief? Anesth Analg, 2006; 102: 1789-1797
57. van Dorp EL, Morariu A, Dahan A: Morphine-6-glucuronide: potency and safety compared with morphine. Expert Opin Pharmacother, 2008; 9: 1955-1961
58. Dahan A, van Dorp E, Smith T, Yassen A: Morphine-6-glucuronide (M6G) for postoperative pain relief. Eur J Pain, 2008; 12: 403-411 (Pubitemid 351312894)
59. Meijerink WJ, Molina PE, Abumrad NN: Mammalian opiate alkaloid synthesis: lessons derived from plant biochemistry. Shock, 1999; 12: 165-173
60. Fricchione G, Zhu W, Cadet P et al: Identification of endogenous morphine and a mu3-like opiate alkaloid receptor in human brain tissue taken from a patient with intractable complex partial epilepsy. Med Sci Monit, 2008; 14(6): CS45-49 (Pubitemid 351929695)
61. Goumon Y, Zhu W, Weeks BS et al: Identification of morphine in the adrenal medullary chromaffin PC-12 cell line. Brain Res Mol Brain Res, 2000; 81: 177-180 (Pubitemid 30734811)
62. Poeaknapo C, Schmidt J, Brandsch M et al: Endogenous formation of morphine in human cells. Proc Natl Acad Sci USA, 2004; 101: 14091-14096 (Pubitemid 39305035)
63. Boettcher C, Fellermeier M, Boettcher C et al: How human neuroblastoma cells make morphine. Proc Natl Acad Sci USA, 2005; 102: 8495-8500 (Pubitemid 40862764)
64. Heurtaux T, Benani A, Moulin D et al: Induction of UGT1A6 isoform by infl ammatory conditions in rat astrocytes. Neuropharmacology, 2006; 50: 317-328 (Pubitemid 43184360)
65. King CD, Rios GR, Assouline JA, Tephly TR: Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identification of 5-hydroxytryptamine as a substrate. Arch Biochem Biophys, 1999; 365: 156-162 (Pubitemid 29394261)
66. Suleman FG, Abid A, Gradinaru D et al: Identification of the uridine diphosphate glucuronosyltransferase isoform UGT1A6 in rat brain and in primary cultures of neurons and astrocytes. Arch Biochem Biophys, 1998; 358: 63-67 (Pubitemid 28471374)
67. Nagano E, Yamada H, Oguri K: Characteristic glucuronidation pattern of physiologic concentration of morphine in rat brain. Life Sci, 2000; 67: 2453-2464 (Pubitemid 30782262)
68. Yamada H, Ishii K, Ishii Y et al: Formation of highly analgesic morphine- 6-glucuronide following physiologic concentration of morphine in human brain. J Toxicol Sci, 2003; 28: 395-401 (Pubitemid 38133218)
69. Brix-Christensen V, Goumon Y, Tonnesen E et al: Endogenous morphine is produced in response to cardiopulmonary bypass in neonatal pigs. Acta Anaesthesiol Scand, 2000; 44: 1204-1208 (Pubitemid 30800351)
70. Brix-Christensen V, Tonnesen E, Sanchez RG et al: Endogenous morphine levels increase following cardiac surgery as part of the antiinfl ammatory response? Int J Cardiol, 1997; 62: 191-197
71. Goumon Y, Bouret S, Casares F et al: Lipopolysaccharide increases endogenous morphine levels in rat brain. Neurosci Lett, 2000; 293: 135-138 (Pubitemid 30750799)
72. Yoshida S, Ohta J, Yamasaki K et al: Effect of surgical stress on endogenous morphine and cytokine levels in the plasma after laparoscopoic or open cholecystectomy. Surg Endosc, 2000; 14: 137-140 (Pubitemid 30080262)
73. Cadet P, Mantione KJ, Stefano GB: Molecular identification and functional expression of mu 3, a novel alternatively spliced variant of the human mu opiate receptor gene. J Immunol, 2003; 170: 5118-5123 (Pubitemid 36554743)
74. Cadet P, Mantione KJ, Zhu W et al: A functionally coupled mu3-like opiate receptor/nitric oxide regulatory pathway in human multi-lineage progenitor cells. J Immunol, 2007; 179: 5839-5844
75. Olsen GD, Bennett WM, Porter GA: Morphine and phenytoin binding to plasma proteins in renal and hepatic failure. Clin Pharmacol Ther, 1975; 17: 677-684
76. Leow KP, Wright AW, Cramond T, Smith MT: Determination of the serum protein binding of oxycodone and morphine using ultrafiltration. Ther Drug Monit, 1993; 15: 440-447 (Pubitemid 23297249)
77. Hengst U, Albrecht H, Hess D, Monard D: The phosphatidylethanolamine- binding protein is the prototype of a novel family of serine protease inhibitors. J Biol Chem, 2001; 276: 535-540 (Pubitemid 32050348)
78. Cadet P, Bilfinger TV, Fimiani C et al: Human vascular and cardiac endothelia express mu opiate receptor transcripts. Endothelium, 2000; 7: 185-191 (Pubitemid 30406708)
79. Stefano GB, Kushnerik V, Rodriquez M, Bilfinger TV: Inhibitory effect of morphine on granulocyte stimulation by tumor necrosis factor and substance P. Int J Immunopharmacol, 1994; 16: 329-334 (Pubitemid 24128115)
80. Stefano GB, Zhu W, Cadet P et al: A hormonal role for endogenous opiate alkaloids: vascular tissues. Neuro Endocrinol Lett, 2002; 23: 21-26 (Pubitemid 34192865)